Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Saved in:
Bibliographic Details
Published inJournal of clinical lipidology Vol. 5; no. 3; pp. S38 - S45
Main Authors Ito, Matthew K., McGowan, Mary P., Moriarty, Patrick M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2011
Subjects
Adult
Blood Component Removal - methods
Contraindications
Coronary Disease - etiology
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hyperlipoproteinemia Type II - complications
Hyperlipoproteinemia Type II - drug therapy
Life Style
Lipoproteins, LDL - isolation & purification
Pregnancy
Pregnancy Complications - therapy
Online AccessGet full text
ISSN1933-2874
1876-4789
DOI10.1016/j.jacl.2011.04.001

Cover

Author Ito, Matthew K.
McGowan, Mary P.
Moriarty, Patrick M.
Author_xml – sequence: 1
  givenname: Matthew K.
  surname: Ito
  fullname: Ito, Matthew K.
  email: itom@ohsu.edu
  organization: Oregon State University/Oregon Health & Science University, Portland, OR, USA
– sequence: 2
  givenname: Mary P.
  surname: McGowan
  fullname: McGowan, Mary P.
  organization: Cholesterol Treatment Center, Concord Hospital, Concord, NH, USA
– sequence: 3
  givenname: Patrick M.
  surname: Moriarty
  fullname: Moriarty, Patrick M.
  organization: The University of Kansas Hospital, Kansas City, KS, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21600528$$D View this record in MEDLINE/PubMed
BookMark eNqFkctu3CAUhlGVqrm0L9BFxa4ru4CNwVE3UZRLpelFVbtGGI4bpthMgYk6j9M3DTOTbLKYrg4c_d_P4fyn6GgOMyD0lpKaEtp9WNZLbXzNCKU1aWtC6At0QqXoqlbI_qic-6apmBTtMTpNaUkI54LwV-iY0a5cmDxB_z7rWf-CCeaMw4iv9eS80x7fblYQzV3wkDLEUianE3Yz1nbtM17p7AqSzvF3MGEquC2dMCc8xjDhfAf4y65RrBZu5Sy-SCkYt-vhq7_FPONvegaPy_3gq6_Ry1H7BG8e6xn6eX314_K2Wny9-XR5sahMK1iuxAi2lwNYqZmEsTHaWDI042B411hBTD8OLeMdGTTvR8Z0RwfeCCN0JwzjTXOG3u99VzH8WZcB1OSSAe_LlGGdlOxk33MuRVG-e1SuhwmsWkU36bhRT1stArkXmBhSijAq4_Lu6zlq5xUlahugWqptgGoboCKtKgEWlD1Dn9wPQh_3EJT93DuIKpkSjwHrIpisbHCH8fNnuPFudkb737D5H_wA4LLMVg
CitedBy_id crossref_primary_10_1016_j_transci_2018_08_004
crossref_primary_10_1007_s11883_014_0465_6
crossref_primary_10_1016_j_atherosclerosissup_2015_02_036
crossref_primary_10_3945_jn_115_215061
crossref_primary_10_1002_clc_22223
crossref_primary_10_1007_s11883_014_0473_6
crossref_primary_10_1016_j_ecl_2015_09_003
crossref_primary_10_31083_j_rcm2411311
crossref_primary_10_1002_jgc4_1266
crossref_primary_10_1016_j_jacl_2015_08_002
crossref_primary_10_1111_j_1365_3083_2012_02734_x
crossref_primary_10_1108_NFS_08_2017_0167
crossref_primary_10_1016_j_jacl_2016_02_003
crossref_primary_10_1093_eurheartj_ehx317
crossref_primary_10_1007_s11886_022_01751_z
crossref_primary_10_1002_phar_1441
crossref_primary_10_1016_j_jacl_2019_08_003
crossref_primary_10_1016_j_jacl_2015_06_010
crossref_primary_10_1016_j_repce_2014_07_010
crossref_primary_10_1016_j_ecl_2015_09_001
crossref_primary_10_1016_j_arteri_2013_07_005
crossref_primary_10_1373_clinchem_2017_279422
crossref_primary_10_1016_j_recesp_2016_10_018
crossref_primary_10_2217_clp_13_74
crossref_primary_10_2217_clp_13_79
crossref_primary_10_1016_j_ccl_2015_01_001
crossref_primary_10_1016_j_jacl_2014_10_002
crossref_primary_10_1016_j_jacl_2014_01_001
crossref_primary_10_1016_j_jacl_2016_03_012
crossref_primary_10_1155_2013_957027
crossref_primary_10_1345_aph_1R127
crossref_primary_10_1016_j_beem_2013_10_004
crossref_primary_10_1016_j_jacl_2015_03_007
crossref_primary_10_1016_j_berh_2011_10_016
crossref_primary_10_1111_vox_12031
crossref_primary_10_1002_mnfr_201600116
crossref_primary_10_3390_pharmaceutics14061258
crossref_primary_10_1007_s12170_012_0231_7
crossref_primary_10_1016_j_jacl_2011_03_001
crossref_primary_10_1016_j_bpobgyn_2015_04_006
crossref_primary_10_1016_j_jacc_2014_01_060
crossref_primary_10_3389_fcvm_2024_1417044
crossref_primary_10_1007_s11883_014_0467_4
crossref_primary_10_1016_j_pepo_2013_09_001
crossref_primary_10_2459_JCM_0000000000000620
crossref_primary_10_2217_clp_13_57
crossref_primary_10_1016_j_rec_2017_01_023
crossref_primary_10_1097_MOL_0b013e3283556c33
crossref_primary_10_1016_j_rccar_2016_05_002
crossref_primary_10_1016_j_jacl_2020_01_009
crossref_primary_10_1007_s40267_013_0087_z
crossref_primary_10_1093_eurheartj_eht015
crossref_primary_10_1093_eurheartj_ehv157
crossref_primary_10_1016_j_jacl_2019_05_002
crossref_primary_10_1002_minf_202300312
crossref_primary_10_1007_s40256_013_0030_7
crossref_primary_10_1016_j_ihjccr_2017_10_003
crossref_primary_10_1016_j_jacl_2013_11_002
crossref_primary_10_2217_clp_13_49
crossref_primary_10_1016_j_amjcard_2016_11_025
crossref_primary_10_1016_j_atherosclerosis_2015_03_014
crossref_primary_10_4155_cli_12_96
crossref_primary_10_1007_s10522_013_9486_8
crossref_primary_10_1007_s11886_013_0391_1
crossref_primary_10_1080_14779072_2023_2218087
crossref_primary_10_1088_1742_6596_1279_1_012017
crossref_primary_10_1016_j_jacl_2013_01_005
crossref_primary_10_1016_j_jacl_2024_05_005
crossref_primary_10_1016_j_lpm_2013_01_053
crossref_primary_10_1016_j_repc_2014_07_007
crossref_primary_10_5551_jat_45708
crossref_primary_10_1038_nrdp_2017_93
crossref_primary_10_1016_j_ccl_2015_02_002
crossref_primary_10_1161_CIRCULATIONAHA_111_059311
crossref_primary_10_1016_j_jacl_2015_09_002
crossref_primary_10_3897_pharmacia_68_e70678
crossref_primary_10_1016_j_acvd_2012_05_011
crossref_primary_10_1016_j_atherosclerosissup_2015_02_024
crossref_primary_10_1097_MOL_0000000000000238
crossref_primary_10_1345_aph_1R202
crossref_primary_10_1161_CIRCULATIONAHA_116_021673
crossref_primary_10_2217_pgs_14_138
crossref_primary_10_1097_HCO_0000000000000083
crossref_primary_10_1016_j_jacl_2017_03_008
crossref_primary_10_1016_j_jacl_2023_08_008
crossref_primary_10_1016_j_jacl_2015_02_003
crossref_primary_10_1097_MOL_0000000000000519
crossref_primary_10_1007_s40265_015_0466_y
crossref_primary_10_1016_j_jacl_2011_04_003
crossref_primary_10_1016_S0304_5412_13_70636_X
crossref_primary_10_1016_j_mayocp_2013_09_003
crossref_primary_10_1016_j_atherosclerosissup_2011_06_001
crossref_primary_10_1097_PAT_0b013e32834efa07
crossref_primary_10_1016_j_atherosclerosis_2019_09_006
crossref_primary_10_1016_j_jacl_2014_07_007
crossref_primary_10_1016_j_jacl_2013_03_002
crossref_primary_10_1080_21678707_2016_1189824
crossref_primary_10_36660_abc_20210788
Cites_doi 10.1093/eurheartj/ehn448
10.1016/j.amjcard.2005.12.014
10.1194/jlr.R800091-JLR200
10.1016/j.amjcard.2006.02.030
10.1056/NEJMoa0800742
10.1016/S0021-9150(02)00251-4
10.1016/j.amjcard.2005.06.006
10.1016/j.ahj.2005.04.003
10.1097/01.mjt.0000155109.69831.a3
10.1111/j.1365-2362.1994.tb01068.x
10.1016/S0002-9149(98)00732-2
10.1016/j.atherosclerosis.2006.02.030
10.1016/j.atherosclerosis.2006.01.002
10.1016/j.ecl.2008.11.011
10.1093/ajcn/56.2.320
10.1016/0021-9150(93)90260-2
10.1046/j.1526-0968.2003.00066.x
10.1161/01.CIR.0000133317.49796.0E
10.1016/S0002-9149(01)01931-2
10.1161/01.CIR.0000035275.64667.A3
10.1016/S0022-3565(24)36992-7
10.1046/j.1526-0968.2002.00426.x
10.5551/jat.4143
10.1002/j.1552-4604.1991.tb03750.x
10.1016/S0021-9150(00)00371-3
10.1016/S0026-0495(98)90127-5
10.1161/01.CIR.95.1.76
10.1001/jama.1984.03340270029025
10.1002/clc.4960240610
10.1016/S0002-9149(97)00965-X
10.1046/j.1526-0968.2003.00078.x
10.1111/j.1526-0968.2004.00172.x
10.1111/j.1774-9987.2005.00236.x
10.1038/sj.mt.6300175
10.1007/s11883-009-0070-2
10.1093/ajcn/69.1.30
10.1345/aph.1K065
10.1373/clinchem.2004.038026
10.2147/VHRM.S13496
10.1016/S0022-2275(20)30168-1
10.1016/S0022-2275(20)37137-6
10.1016/S0022-2275(20)39941-7
10.1016/S0025-7125(05)70205-4
10.1016/j.ahj.2010.09.023
10.1056/NEJMoa011090
10.1016/j.amjcard.2005.12.013
10.1016/S0021-9150(02)00330-1
10.1161/circ.106.25.3143
10.1161/01.CIR.0000018744.58460.62
10.1161/CIR.0b013e31820c7a50
10.1007/BF00190741
10.1016/S0140-6736(95)92961-4
10.1007/s11936-006-0049-z
10.1016/S0002-9149(03)00530-7
10.1042/CS19980326
10.1111/j.1755-5922.2010.00189.x
10.1161/01.CIR.93.10.1826
10.1159/000293016
10.1016/j.clinthera.2010.04.014
10.1016/j.jada.2006.07.009
10.1016/S0002-9149(98)00692-4
10.1053/meta.2002.34016
10.1592/phco.21.5.481.34499
10.1016/S0002-9149(98)00955-2
10.1210/jc.2008-1270
10.1136/bmj.a1095
10.1002/jca.20000
10.1016/S0002-9149(97)00947-8
10.1016/j.amjcard.2005.08.056
10.1016/0021-9150(92)90170-L
10.3945/jn.108.095125
10.1038/nrendo.2009.151
10.1111/j.1744-9987.2007.00449.x
10.1016/S0002-9149(00)01410-7
10.1016/j.jacl.2010.08.015
10.1097/MOL.0b013e328340b8e7
10.1016/S0002-9149(98)00952-7
ContentType Journal Article
Copyright 2011 National Lipid Association
Copyright_xml – notice: 2011 National Lipid Association
CorporateAuthor National Lipid Association Expert Panel on Familial Hypercholesterolemia
CorporateAuthor_xml – name: National Lipid Association Expert Panel on Familial Hypercholesterolemia
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jacl.2011.04.001
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1876-4789
EndPage S45
ExternalDocumentID 21600528
10_1016_j_jacl_2011_04_001
S1933287411005368
Genre Journal Article
Practice Guideline
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OA.
OAUVE
OL~
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
Z5R
~G-
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c472t-7fed98bed8a28ef3cacd0b3fbc563d70c9fb42560ba59f22a61b537c7a67c2533
IEDL.DBID .~1
ISSN 1933-2874
IngestDate Thu Sep 04 22:12:19 EDT 2025
Mon Jul 21 05:58:30 EDT 2025
Tue Jul 01 05:26:23 EDT 2025
Thu Apr 24 22:57:09 EDT 2025
Fri Feb 23 02:34:02 EST 2024
Tue Aug 26 19:31:36 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-7fed98bed8a28ef3cacd0b3fbc563d70c9fb42560ba59f22a61b537c7a67c2533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
PMID 21600528
PQID 868995587
PQPubID 23479
ParticipantIDs proquest_miscellaneous_868995587
pubmed_primary_21600528
crossref_citationtrail_10_1016_j_jacl_2011_04_001
crossref_primary_10_1016_j_jacl_2011_04_001
elsevier_sciencedirect_doi_10_1016_j_jacl_2011_04_001
elsevier_clinicalkey_doi_10_1016_j_jacl_2011_04_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-06-01
PublicationDateYYYYMMDD 2011-06-01
PublicationDate_xml – month: 06
  year: 2011
  text: 2011-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical lipidology
PublicationTitleAlternate J Clin Lipidol
PublicationYear 2011
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Morgan, Capuzzi, Guyton (bib44) 1998; 82
Rissanen, Yla-Herttuala (bib80) 2007; 15
Drood, Zimetbaum, Frishman (bib42) 1991; 31
Goldammer, Wiltschnig, Heinz (bib25) 2002; 51
Gordon, Kelsey, Dau (bib55) 1998; 81
National Institute for Health and Clinical Excellence. Clinical guidelines and evidence review for familial hypercholesterolemias: the identification and management of adults and children with familial hypercholesterolemia. 2008 (Clinical guidelines 71)
Lichtenstein, Ausman, Jalbert (bib13) 2002; 43
(bib26) 1994; 344
Igarashi, Tsuji, Nishimura, Horimoto (bib64) 2004; 19
Huijgen, Abbink, Bruckert (bib41) 2010; 32
Tamai, Matsuoka, Itabe, Wada, Kohno, Imaizumi (bib63) 1997; 95
Kwiterovich (bib6) 2008; 93
Caron, White (bib82) 2001; 21
Schettler, Wieland, Armstrong, Kleinoeder, Grunewald, Muller (bib49) 2002; 6
Mabuchi, Koizumi, Shimizu (bib61) 1998; 82
Amundsen, Khoury, Iversen, Bergei, Ose, Tonstad (bib73) 2006; 189
Klingel, Gohlen, Schwarting, Himmelsbach, Straube (bib74) 2003; 7
Brown, Zhao, Chait, Fisher, Cheung, Morse (bib29) 2001; 345
Schuff-Werner, Gohike, Bartmann (bib58) 1994; 24
Keller (bib67) 2007; 11
Marks, Thorogood, Neil, Humphries (bib23) 2003; 168
Gagne, Gauder, Bruckert (bib35) 2002; 105
Goldberg, Ostlund, Bateman, Schimmoeller, McPherson, Spilburg (bib22) 2006; 97
Guyton, Capuzzi (bib45) 1998; 82
Marais, Naoumova, Firth, Penny, Neuwirth, Thompson (bib53) 1997; 38
Tatami, Inove, Itoh (bib56) 1992; 95
.
(bib2) 2002; 106
Pfohl, Naoumova, Klass (bib54) 1994; 35
Kroon, Aengevaeren, van den Werf (bib60) 1996; 93
Thompson, Maher, Matthews (bib59) 1995; 345
Loke, Viegas, Kek, Rauff, Thai, Ratnam (bib71) 1991; 32
Jones, Davidson, Stein (bib28) 2003; 92
(bib1) 2011; 123
Illingworth (bib12) 2000; 84
van Heek, France, Compton (bib34) 1997; 283
Stein (bib77) 2009; 38
Wierzbicki, Humphries, Minhas (bib9) 2008; 337
Hamilton-Craig, Kostner, Colquhoun, Woodhouse (bib38) 2010; 6
(bib40) 1984; 251
Stone, Bilek, Rosenbaum (bib76) 2005; 96
Davidson, Toth, Weiss (bib20) 2001; 24
Goldberg (bib81) 2010; 4
Kroon, van’t Hof, Demacker, Stalenhoef (bib52) 2000; 152
Grundy, Cleeman, Merz (bib10) 2004; 110
Connor, Connor (bib19) 1989; 9
Kobayashi, Yamashita, Tasaki (bib66) 2004; 8
Avellone, Di Garbo, Guarnotta, Scaglione, Parrinello, Purpura, Torres, Campisi (bib39) 2010; 29
Brown, Roener, Willett, Sacks (bib15) 1999; 69
Cohen, Anania, Chalasani (bib30) 2006; 97
McGowan, Proulx (bib84) 2009; 11
Sato, Amano (bib65) 2003; 7
Rees (bib7) 2008; 29
de Gennes, Touraine, Maunand, Truffert, Laudat (bib48) 1967; 118
Zema (bib36) 2005; 12
Jacobson (bib47) 2009; 5
Grundy (bib75) 2001; 88
Gepner, Piper, Johnson, Fiore, Baker, Stein (bib18) 2011; 161
Kastelein, Adkim, Stroes (bib37) 2008; 358
Wolfe, Vartanian, Ross (bib46) 2001; 87
Goldstein, Hobbs, Brown (bib3) 2001
Thompson (bib50) 2003; 167
Thompson, Clarkson, Rosenson (bib31) 2006; 97
Martin, Davies, Hayavi, Hartland, Dunne (bib72) 1999; 96
Ritcher, Donner, Hofling, Schwandt (bib62) 1998; 47
Hansson (bib78) 2002; 106
Bruckert, Rosenbaum (bib14) 2011; 22
Zhou, Rahme, Pilote (bib33) 2006; 151
Demonty, Ras, van der Knaap (bib16) 2009; 139
Thompsen, Thompson (bib69) 2006; 189
U.S. Food and Drug Administration (FDA). PMA final decisions rendered for September 1997. H.E.L.P. Accessed February 8, 2011. Available at
Dattilo, Kris-Etherton (bib17) 1992; 56
Jones, Kafonek, Laurora, Hunninghake (bib27) 1998; 81
Badimon, Vilahur, Padro (bib83) 2010; 28
Harada-Shiba, Sugisawa, Makino (bib11) 2010; 17
Whitfield, Barrett, van Bockxmeer, Burnett (bib4) 2004; 50
McKenney, Davidson, Jacobson, Guyton (bib32) 2006
Goldberg (bib43) 1998; 82
Feher, Webb, Patel (bib24) 1993; 103
Ito (bib79) 2007; 41
Castro Cabezas, de Vries, Van Oostrom, Iestra, van Staveren (bib21) 2006; 106
Horton, Cohen, Hobbs (bib5) 2009; 50
Moriarty (bib51) 2006; 8
Bambauer (bib68) 2005; 9
Waidner, Franzen, Voelker (bib57) 1994; 72
Wierzbicki (10.1016/j.jacl.2011.04.001_bib9) 2008; 337
Pfohl (10.1016/j.jacl.2011.04.001_bib54) 1994; 35
Keller (10.1016/j.jacl.2011.04.001_bib67) 2007; 11
Amundsen (10.1016/j.jacl.2011.04.001_bib73) 2006; 189
Dattilo (10.1016/j.jacl.2011.04.001_bib17) 1992; 56
Whitfield (10.1016/j.jacl.2011.04.001_bib4) 2004; 50
Goldberg (10.1016/j.jacl.2011.04.001_bib22) 2006; 97
Gordon (10.1016/j.jacl.2011.04.001_bib55) 1998; 81
Hansson (10.1016/j.jacl.2011.04.001_bib78) 2002; 106
Bambauer (10.1016/j.jacl.2011.04.001_bib68) 2005; 9
McGowan (10.1016/j.jacl.2011.04.001_bib84) 2009; 11
Kastelein (10.1016/j.jacl.2011.04.001_bib37) 2008; 358
Marais (10.1016/j.jacl.2011.04.001_bib53) 1997; 38
Caron (10.1016/j.jacl.2011.04.001_bib82) 2001; 21
Wolfe (10.1016/j.jacl.2011.04.001_bib46) 2001; 87
Feher (10.1016/j.jacl.2011.04.001_bib24) 1993; 103
Gagne (10.1016/j.jacl.2011.04.001_bib35) 2002; 105
Rissanen (10.1016/j.jacl.2011.04.001_bib80) 2007; 15
Goldberg (10.1016/j.jacl.2011.04.001_bib43) 1998; 82
Thompson (10.1016/j.jacl.2011.04.001_bib31) 2006; 97
Gepner (10.1016/j.jacl.2011.04.001_bib18) 2011; 161
McKenney (10.1016/j.jacl.2011.04.001_bib32) 2006
Cohen (10.1016/j.jacl.2011.04.001_bib30) 2006; 97
Bruckert (10.1016/j.jacl.2011.04.001_bib14) 2011; 22
de Gennes (10.1016/j.jacl.2011.04.001_bib48) 1967; 118
Moriarty (10.1016/j.jacl.2011.04.001_bib51) 2006; 8
Demonty (10.1016/j.jacl.2011.04.001_bib16) 2009; 139
Connor (10.1016/j.jacl.2011.04.001_bib19) 1989; 9
Drood (10.1016/j.jacl.2011.04.001_bib42) 1991; 31
Badimon (10.1016/j.jacl.2011.04.001_bib83) 2010; 28
Martin (10.1016/j.jacl.2011.04.001_bib72) 1999; 96
Ito (10.1016/j.jacl.2011.04.001_bib79) 2007; 41
Goldstein (10.1016/j.jacl.2011.04.001_bib3) 2001
Grundy (10.1016/j.jacl.2011.04.001_bib10) 2004; 110
Zhou (10.1016/j.jacl.2011.04.001_bib33) 2006; 151
(10.1016/j.jacl.2011.04.001_bib26) 1994; 344
Igarashi (10.1016/j.jacl.2011.04.001_bib64) 2004; 19
Mabuchi (10.1016/j.jacl.2011.04.001_bib61) 1998; 82
Horton (10.1016/j.jacl.2011.04.001_bib5) 2009; 50
(10.1016/j.jacl.2011.04.001_bib1) 2011; 123
(10.1016/j.jacl.2011.04.001_bib2) 2002; 106
Davidson (10.1016/j.jacl.2011.04.001_bib20) 2001; 24
Brown (10.1016/j.jacl.2011.04.001_bib15) 1999; 69
Huijgen (10.1016/j.jacl.2011.04.001_bib41) 2010; 32
Kwiterovich (10.1016/j.jacl.2011.04.001_bib6) 2008; 93
10.1016/j.jacl.2011.04.001_bib70
Thompson (10.1016/j.jacl.2011.04.001_bib50) 2003; 167
Kroon (10.1016/j.jacl.2011.04.001_bib60) 1996; 93
Thompson (10.1016/j.jacl.2011.04.001_bib59) 1995; 345
Castro Cabezas (10.1016/j.jacl.2011.04.001_bib21) 2006; 106
Jones (10.1016/j.jacl.2011.04.001_bib27) 1998; 81
Schettler (10.1016/j.jacl.2011.04.001_bib49) 2002; 6
Kroon (10.1016/j.jacl.2011.04.001_bib52) 2000; 152
Rees (10.1016/j.jacl.2011.04.001_bib7) 2008; 29
(10.1016/j.jacl.2011.04.001_bib40) 1984; 251
Waidner (10.1016/j.jacl.2011.04.001_bib57) 1994; 72
Zema (10.1016/j.jacl.2011.04.001_bib36) 2005; 12
Harada-Shiba (10.1016/j.jacl.2011.04.001_bib11) 2010; 17
Marks (10.1016/j.jacl.2011.04.001_bib23) 2003; 168
Schuff-Werner (10.1016/j.jacl.2011.04.001_bib58) 1994; 24
Loke (10.1016/j.jacl.2011.04.001_bib71) 1991; 32
Goldammer (10.1016/j.jacl.2011.04.001_bib25) 2002; 51
Tatami (10.1016/j.jacl.2011.04.001_bib56) 1992; 95
Illingworth (10.1016/j.jacl.2011.04.001_bib12) 2000; 84
Grundy (10.1016/j.jacl.2011.04.001_bib75) 2001; 88
van Heek (10.1016/j.jacl.2011.04.001_bib34) 1997; 283
Jacobson (10.1016/j.jacl.2011.04.001_bib47) 2009; 5
Hamilton-Craig (10.1016/j.jacl.2011.04.001_bib38) 2010; 6
Goldberg (10.1016/j.jacl.2011.04.001_bib81) 2010; 4
10.1016/j.jacl.2011.04.001_bib8
Avellone (10.1016/j.jacl.2011.04.001_bib39) 2010; 29
Stein (10.1016/j.jacl.2011.04.001_bib77) 2009; 38
Ritcher (10.1016/j.jacl.2011.04.001_bib62) 1998; 47
Sato (10.1016/j.jacl.2011.04.001_bib65) 2003; 7
Tamai (10.1016/j.jacl.2011.04.001_bib63) 1997; 95
Guyton (10.1016/j.jacl.2011.04.001_bib45) 1998; 82
Klingel (10.1016/j.jacl.2011.04.001_bib74) 2003; 7
Lichtenstein (10.1016/j.jacl.2011.04.001_bib13) 2002; 43
Jones (10.1016/j.jacl.2011.04.001_bib28) 2003; 92
Kobayashi (10.1016/j.jacl.2011.04.001_bib66) 2004; 8
Stone (10.1016/j.jacl.2011.04.001_bib76) 2005; 96
Brown (10.1016/j.jacl.2011.04.001_bib29) 2001; 345
Thompsen (10.1016/j.jacl.2011.04.001_bib69) 2006; 189
Morgan (10.1016/j.jacl.2011.04.001_bib44) 1998; 82
References_xml – volume: 6
  start-page: 381
  year: 2002
  end-page: 383
  ident: bib49
  article-title: Participants of the Gottingen Consensus Conferences. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management
  publication-title: Ther Apher
– volume: 105
  start-page: 2469
  year: 2002
  end-page: 2475
  ident: bib35
  article-title: Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
  publication-title: Circulation
– volume: 96
  start-page: 421
  year: 1999
  end-page: 425
  ident: bib72
  article-title: Is normal pregnancy atherogenic?
  publication-title: Clin Sci (Lond)
– volume: 15
  start-page: 1233
  year: 2007
  end-page: 1247
  ident: bib80
  article-title: Current status of cardiovascular gene therapy
  publication-title: Molec Ther
– volume: 6
  start-page: 1023
  year: 2010
  end-page: 1037
  ident: bib38
  article-title: Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
  publication-title: Vasc Health Risk Manag
– volume: 189
  start-page: 31
  year: 2006
  end-page: 38
  ident: bib69
  article-title: A systematic review of LDL apheresis in the treatment of cardiovascular disease
  publication-title: Atherosclerosis
– volume: 11
  start-page: 470
  year: 2009
  end-page: 476
  ident: bib84
  article-title: Nutritional supplements and serum lipids: does anything work?
  publication-title: Curr Atheroscler Rep
– volume: 97
  start-page: 376
  year: 2006
  end-page: 379
  ident: bib22
  article-title: Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs
  publication-title: Am J Cardiol
– volume: 8
  start-page: 282
  year: 2006
  end-page: 288
  ident: bib51
  article-title: LDL-apheresis therapy
  publication-title: Curr Treat Options Cardiovasc Med
– volume: 24
  start-page: 724
  year: 1994
  end-page: 732
  ident: bib58
  article-title: The HELP-LDL-apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL cholesterol plasma concentration and the course of coronary heart disease
  publication-title: Eur J Clin Invest
– volume: 47
  start-page: 863
  year: 1998
  end-page: 868
  ident: bib62
  article-title: Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia
  publication-title: Metabolism
– volume: 82
  start-page: 82U
  year: 1998
  end-page: 84U
  ident: bib45
  article-title: Treatment of hyperlipidemia with combined niacin-statin regimens
  publication-title: Am J Cardiol
– volume: 95
  start-page: 1
  year: 1992
  end-page: 13
  ident: bib56
  article-title: Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators
  publication-title: Atherosclerosis
– start-page: 89C
  year: 2006
  end-page: 94C
  ident: bib32
  article-title: National Lipid Association Statin Safety Task Force Liver Expert Panel. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
  publication-title: Am J Cardiol
– volume: 344
  start-page: 1383
  year: 1994
  end-page: 1389
  ident: bib26
  article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  publication-title: Lancet
– volume: 81
  start-page: 582
  year: 1998
  end-page: 587
  ident: bib27
  article-title: Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
  publication-title: Am J Cardiol
– volume: 81
  start-page: 407
  year: 1998
  end-page: 411
  ident: bib55
  article-title: Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group
  publication-title: Am J Cardiol
– volume: 8
  start-page: 383
  year: 2004
  end-page: 389
  ident: bib66
  article-title: Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echocardiography after single LDL apheresis
  publication-title: Ther Apher Dial
– volume: 337
  start-page: 509
  year: 2008
  end-page: 510
  ident: bib9
  article-title: Familial hypercholesterolemia: summary of NICE guidance
  publication-title: BMJ
– start-page: 2863
  year: 2001
  end-page: 2913
  ident: bib3
  article-title: Familial hypercholesterolemia
  publication-title: The Metabolic and molecular basis of inherited disease
– volume: 12
  start-page: 306
  year: 2005
  end-page: 310
  ident: bib36
  article-title: Colesevelam HCL and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia
  publication-title: Am J Ther
– volume: 251
  start-page: 351
  year: 1984
  end-page: 364
  ident: bib40
  article-title: The Lipid Research Clinics coronary primary prevention trial results, I: reduction in the incidence of coronary heart disease
  publication-title: JAMA
– volume: 82
  start-page: 1489
  year: 1998
  end-page: 1495
  ident: bib61
  article-title: Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group
  publication-title: Am J Cardiol
– volume: 88
  start-page: 23J
  year: 2001
  end-page: 27J
  ident: bib75
  article-title: United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy
  publication-title: Am J Cardiol
– volume: 21
  start-page: 481
  year: 2001
  end-page: 487
  ident: bib82
  article-title: Evaluation of the antihyperlipidemic properties of dietary supplements
  publication-title: Pharmacotherapy
– volume: 283
  start-page: 157
  year: 1997
  end-page: 163
  ident: bib34
  article-title: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH5825, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461
  publication-title: J Pharmacol Exp Ther
– volume: 82
  start-page: 35U
  year: 1998
  end-page: 38U
  ident: bib43
  article-title: Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study
  publication-title: Am J Cardiol
– volume: 69
  start-page: 30
  year: 1999
  end-page: 42
  ident: bib15
  article-title: Cholesterol lowering effects of dietary fiber: a meta-analysis
  publication-title: Am J Clin Nutr
– volume: 56
  start-page: 320
  year: 1992
  end-page: 328
  ident: bib17
  article-title: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis
  publication-title: Am J Clin Nutr
– volume: 50
  start-page: S172
  year: 2009
  end-page: S177
  ident: bib5
  article-title: PCSK9: A convertase that coordinates LDL catabolism
  publication-title: J Lipid Res
– volume: 84
  start-page: 23
  year: 2000
  end-page: 42
  ident: bib12
  article-title: Management of hypercholesterolemia
  publication-title: Med Clin North Am
– volume: 106
  start-page: 3143
  year: 2002
  end-page: 3421
  ident: bib2
  article-title: Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report
  publication-title: Circulation
– volume: 161
  start-page: 145
  year: 2011
  end-page: 151
  ident: bib18
  article-title: Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial
  publication-title: Am Heart J
– volume: 358
  start-page: 1431
  year: 2008
  end-page: 1443
  ident: bib37
  article-title: Simvastatin with or without ezetimibe in familial hypercholesterolemia
  publication-title: N Engl J Med
– volume: 11
  start-page: 2
  year: 2007
  end-page: 8
  ident: bib67
  article-title: Apheresis in coronary heart disease with elevated Lp(a): a review of Lp(a) as a risk factor and its management
  publication-title: Ther Apher Dial
– volume: 96
  start-page: 53E
  year: 2005
  end-page: 59E
  ident: bib76
  article-title: Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options
  publication-title: Am J Cardiol
– volume: 118
  start-page: 1377
  year: 1967
  end-page: 1402
  ident: bib48
  article-title: Homozygous cutaneo-tendinous forms of hypercholesterolemic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment
  publication-title: Bull Mem Soc Med Hop Paris
– volume: 95
  start-page: 76
  year: 1997
  end-page: 82
  ident: bib63
  article-title: Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans
  publication-title: Circulation
– volume: 106
  start-page: 1599
  year: 2002
  end-page: 1601
  ident: bib78
  article-title: Vaccination against atherosclerosis: science or fiction?
  publication-title: Circulation
– volume: 29
  start-page: 2583
  year: 2008
  end-page: 2584
  ident: bib7
  article-title: Familial hypercholesterolaemia: underdiagnosed and undertreated
  publication-title: Eur Heart J
– volume: 106
  start-page: 1564
  year: 2006
  end-page: 1569
  ident: bib21
  article-title: Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins
  publication-title: J Am Diet Assoc
– volume: 82
  start-page: 29U
  year: 1998
  end-page: 34U
  ident: bib44
  article-title: A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients
  publication-title: Am J Cardiol
– volume: 41
  start-page: 1669
  year: 2007
  end-page: 1678
  ident: bib79
  article-title: ISIS 301012 Gene Therapy for Hypercholesterolemia: Sense, Antisense, or Nonsense?
  publication-title: Ann Pharmacother
– volume: 167
  start-page: 1
  year: 2003
  end-page: 13
  ident: bib50
  article-title: LDL apheresis
  publication-title: Atherosclerosis
– volume: 22
  start-page: 43
  year: 2011
  end-page: 48
  ident: bib14
  article-title: Lowering LDL cholesterol through diet: potential role in the statin era
  publication-title: Curr Opin Lipidol
– reference: .
– volume: 110
  start-page: 227
  year: 2004
  end-page: 239
  ident: bib10
  article-title: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
  publication-title: Circulation
– volume: 17
  start-page: 667
  year: 2010
  end-page: 674
  ident: bib11
  article-title: Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia
  publication-title: J Atheroscler Thromb
– volume: 93
  start-page: 1826
  year: 1996
  end-page: 1835
  ident: bib60
  article-title: LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment of coronary atherosclerosis
  publication-title: Circulation
– volume: 345
  start-page: 1583
  year: 2001
  end-page: 1592
  ident: bib29
  article-title: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
  publication-title: N Engl J Med
– volume: 168
  start-page: 1
  year: 2003
  end-page: 14
  ident: bib23
  article-title: A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
  publication-title: Atherosclerosis
– volume: 7
  start-page: 419
  year: 2003
  end-page: 424
  ident: bib65
  article-title: Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis
  publication-title: Ther Apher Dial
– volume: 97
  start-page: 77C
  year: 2006
  end-page: 81C
  ident: bib30
  article-title: An assessment of statin safety by hepatologists
  publication-title: Am J Cardiol
– volume: 189
  start-page: 451
  year: 2006
  end-page: 457
  ident: bib73
  article-title: Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
  publication-title: Atherosclerosis
– volume: 29
  start-page: 514
  year: 2010
  end-page: 524
  ident: bib39
  article-title: Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia
  publication-title: Int Angiol
– volume: 9
  start-page: 142
  year: 2005
  end-page: 147
  ident: bib68
  article-title: Is lipoprotein(a)-apheresis useful?
  publication-title: Ther Apher Dial
– volume: 72
  start-page: 858
  year: 1994
  end-page: 863
  ident: bib57
  article-title: The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study
  publication-title: Clin Investig
– volume: 93
  start-page: 4200
  year: 2008
  end-page: 4209
  ident: bib6
  article-title: Recognition and management of dyslipidemia in children and adolescents
  publication-title: J Clin Endocrinol Metab
– volume: 19
  start-page: 11
  year: 2004
  end-page: 16
  ident: bib64
  article-title: Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia
  publication-title: J Clin Apher
– volume: 97
  start-page: 69C
  year: 2006
  end-page: 76C
  ident: bib31
  article-title: National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by muscle experts
  publication-title: Am J Cardiol
– volume: 92
  start-page: 152
  year: 2003
  end-page: 160
  ident: bib28
  article-title: Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR∗ Trial)
  publication-title: Am J Cardiol
– volume: 32
  start-page: 144
  year: 1991
  end-page: 147
  ident: bib71
  article-title: Lipid profiles during and after normal pregnancy
  publication-title: Gynecol Obstet Invest
– volume: 32
  start-page: 615
  year: 2010
  end-page: 625
  ident: bib41
  article-title: Trip Study Group. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind controlled trial
  publication-title: Clin Ther
– volume: 103
  start-page: 171
  year: 1993
  end-page: 180
  ident: bib24
  article-title: Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia
  publication-title: Atherosclerosis
– volume: 38
  start-page: 99
  year: 2009
  end-page: 119
  ident: bib77
  article-title: Other therapies for reducing low-density lipoprotein cholesterol: medications in development
  publication-title: Endocrinol Metab Clin North Am
– volume: 4
  start-page: 350
  year: 2010
  end-page: 356
  ident: bib81
  article-title: NLA Symposium on Familial Hypercholesterolemia. Novel therapies and new targets of treatment familial hypercholesterolemia
  publication-title: J Clin Lipidol
– volume: 51
  start-page: 976
  year: 2002
  end-page: 980
  ident: bib25
  article-title: Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia
  publication-title: Metabolism
– volume: 139
  start-page: 271
  year: 2009
  end-page: 284
  ident: bib16
  article-title: Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake
  publication-title: J Nutr
– volume: 24
  start-page: 467
  year: 2001
  end-page: 474
  ident: bib20
  article-title: Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia
  publication-title: Clin Cardiol
– volume: 31
  start-page: 641
  year: 1991
  end-page: 650
  ident: bib42
  article-title: Nicotinic acid for the treatment of hyperlipoproteinemia
  publication-title: J Clin Pharmacol
– volume: 38
  start-page: 2071
  year: 1997
  end-page: 2078
  ident: bib53
  article-title: Decreased production of low-density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
  publication-title: J Lipid Res
– volume: 35
  start-page: 1946
  year: 1994
  end-page: 1955
  ident: bib54
  article-title: Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG CoA reductase inhibitor therapy
  publication-title: J Lipid Res
– volume: 345
  start-page: 811
  year: 1995
  end-page: 816
  ident: bib59
  article-title: Familial Hypercholesterolemia Regression Study: a randomised trial of low-density-lipoprotein apheresis
  publication-title: Lancet
– reference: National Institute for Health and Clinical Excellence. Clinical guidelines and evidence review for familial hypercholesterolemias: the identification and management of adults and children with familial hypercholesterolemia. 2008 (Clinical guidelines 71)
– volume: 9
  start-page: I91
  year: 1989
  end-page: 105
  ident: bib19
  article-title: Dietary treatment of familial hypercholesterolemia
  publication-title: Arteriosclerosis
– volume: 151
  start-page: 273
  year: 2006
  end-page: 281
  ident: bib33
  article-title: Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention
  publication-title: Am Heart J
– volume: 152
  start-page: 519
  year: 2000
  end-page: 526
  ident: bib52
  article-title: The rebound of lipoproteins after LDL apheresis. Kinetics and estimation of mean lipoprotein levels
  publication-title: Atherosclerosis
– volume: 7
  start-page: 359
  year: 2003
  end-page: 364
  ident: bib74
  article-title: Differential indication of lipoprotein apheresis during pregnancy
  publication-title: Ther Apher Dial
– volume: 43
  start-page: 264
  year: 2002
  end-page: 273
  ident: bib13
  article-title: Efficacy of Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects
  publication-title: J Lipid Res
– volume: 5
  start-page: 507
  year: 2009
  end-page: 518
  ident: bib47
  article-title: Myopathy with statin-fibrate combination therapy: clinical considerations
  publication-title: Nat Rev Endocrinol
– volume: 50
  start-page: 1725
  year: 2004
  end-page: 1732
  ident: bib4
  article-title: Lipid disorders and mutations in the Apo B gene
  publication-title: Clin Chem
– volume: 87
  start-page: 476
  year: 2001
  end-page: 479
  ident: bib46
  article-title: Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
  publication-title: Am J Cardiol
– volume: 123
  start-page: 459
  year: 2011
  end-page: 463
  ident: bib1
  article-title: Executive Summary: Heart Disease and Stroke Statistics 2011 Update: A Report from the American Heart Association. American Heart Association Heart Disease and Stroke Statistics Writing Group
  publication-title: Circulation
– reference: U.S. Food and Drug Administration (FDA). PMA final decisions rendered for September 1997. H.E.L.P. Accessed February 8, 2011. Available at
– volume: 28
  start-page: 202
  year: 2010
  end-page: 215
  ident: bib83
  article-title: Nutraceuticals and atherosclerosis: human trials
  publication-title: Cardiovasc Ther
– volume: 29
  start-page: 2583
  year: 2008
  ident: 10.1016/j.jacl.2011.04.001_bib7
  article-title: Familial hypercholesterolaemia: underdiagnosed and undertreated
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehn448
– volume: 97
  start-page: 77C
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib30
  article-title: An assessment of statin safety by hepatologists
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.12.014
– volume: 50
  start-page: S172
  year: 2009
  ident: 10.1016/j.jacl.2011.04.001_bib5
  article-title: PCSK9: A convertase that coordinates LDL catabolism
  publication-title: J Lipid Res
  doi: 10.1194/jlr.R800091-JLR200
– start-page: 89C
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib32
  article-title: National Lipid Association Statin Safety Task Force Liver Expert Panel. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.02.030
– volume: 358
  start-page: 1431
  year: 2008
  ident: 10.1016/j.jacl.2011.04.001_bib37
  article-title: Simvastatin with or without ezetimibe in familial hypercholesterolemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0800742
– volume: 167
  start-page: 1
  year: 2003
  ident: 10.1016/j.jacl.2011.04.001_bib50
  article-title: LDL apheresis
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(02)00251-4
– volume: 96
  start-page: 53E
  year: 2005
  ident: 10.1016/j.jacl.2011.04.001_bib76
  article-title: Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.06.006
– volume: 151
  start-page: 273
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib33
  article-title: Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2005.04.003
– volume: 118
  start-page: 1377
  year: 1967
  ident: 10.1016/j.jacl.2011.04.001_bib48
  article-title: Homozygous cutaneo-tendinous forms of hypercholesterolemic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment
  publication-title: Bull Mem Soc Med Hop Paris
– volume: 12
  start-page: 306
  year: 2005
  ident: 10.1016/j.jacl.2011.04.001_bib36
  article-title: Colesevelam HCL and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia
  publication-title: Am J Ther
  doi: 10.1097/01.mjt.0000155109.69831.a3
– volume: 24
  start-page: 724
  year: 1994
  ident: 10.1016/j.jacl.2011.04.001_bib58
  publication-title: Eur J Clin Invest
  doi: 10.1111/j.1365-2362.1994.tb01068.x
– volume: 82
  start-page: 29U
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib44
  article-title: A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(98)00732-2
– volume: 344
  start-page: 1383
  year: 1994
  ident: 10.1016/j.jacl.2011.04.001_bib26
  article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  publication-title: Lancet
– volume: 29
  start-page: 514
  year: 2010
  ident: 10.1016/j.jacl.2011.04.001_bib39
  article-title: Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia
  publication-title: Int Angiol
– volume: 189
  start-page: 31
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib69
  article-title: A systematic review of LDL apheresis in the treatment of cardiovascular disease
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.02.030
– volume: 189
  start-page: 451
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib73
  article-title: Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.01.002
– volume: 38
  start-page: 99
  year: 2009
  ident: 10.1016/j.jacl.2011.04.001_bib77
  article-title: Other therapies for reducing low-density lipoprotein cholesterol: medications in development
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2008.11.011
– volume: 56
  start-page: 320
  year: 1992
  ident: 10.1016/j.jacl.2011.04.001_bib17
  article-title: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/56.2.320
– volume: 103
  start-page: 171
  year: 1993
  ident: 10.1016/j.jacl.2011.04.001_bib24
  article-title: Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia
  publication-title: Atherosclerosis
  doi: 10.1016/0021-9150(93)90260-2
– ident: 10.1016/j.jacl.2011.04.001_bib70
– volume: 7
  start-page: 359
  year: 2003
  ident: 10.1016/j.jacl.2011.04.001_bib74
  article-title: Differential indication of lipoprotein apheresis during pregnancy
  publication-title: Ther Apher Dial
  doi: 10.1046/j.1526-0968.2003.00066.x
– volume: 110
  start-page: 227
  year: 2004
  ident: 10.1016/j.jacl.2011.04.001_bib10
  article-title: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000133317.49796.0E
– volume: 88
  start-page: 23J
  year: 2001
  ident: 10.1016/j.jacl.2011.04.001_bib75
  article-title: United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(01)01931-2
– volume: 106
  start-page: 1599
  year: 2002
  ident: 10.1016/j.jacl.2011.04.001_bib78
  article-title: Vaccination against atherosclerosis: science or fiction?
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000035275.64667.A3
– volume: 283
  start-page: 157
  year: 1997
  ident: 10.1016/j.jacl.2011.04.001_bib34
  article-title: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH5825, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(24)36992-7
– volume: 6
  start-page: 381
  year: 2002
  ident: 10.1016/j.jacl.2011.04.001_bib49
  article-title: Participants of the Gottingen Consensus Conferences. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management
  publication-title: Ther Apher
  doi: 10.1046/j.1526-0968.2002.00426.x
– volume: 17
  start-page: 667
  year: 2010
  ident: 10.1016/j.jacl.2011.04.001_bib11
  article-title: Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.4143
– volume: 31
  start-page: 641
  year: 1991
  ident: 10.1016/j.jacl.2011.04.001_bib42
  article-title: Nicotinic acid for the treatment of hyperlipoproteinemia
  publication-title: J Clin Pharmacol
  doi: 10.1002/j.1552-4604.1991.tb03750.x
– volume: 152
  start-page: 519
  year: 2000
  ident: 10.1016/j.jacl.2011.04.001_bib52
  article-title: The rebound of lipoproteins after LDL apheresis. Kinetics and estimation of mean lipoprotein levels
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(00)00371-3
– volume: 47
  start-page: 863
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib62
  article-title: Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia
  publication-title: Metabolism
  doi: 10.1016/S0026-0495(98)90127-5
– volume: 95
  start-page: 76
  year: 1997
  ident: 10.1016/j.jacl.2011.04.001_bib63
  article-title: Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans
  publication-title: Circulation
  doi: 10.1161/01.CIR.95.1.76
– volume: 251
  start-page: 351
  year: 1984
  ident: 10.1016/j.jacl.2011.04.001_bib40
  article-title: The Lipid Research Clinics coronary primary prevention trial results, I: reduction in the incidence of coronary heart disease
  publication-title: JAMA
  doi: 10.1001/jama.1984.03340270029025
– volume: 24
  start-page: 467
  year: 2001
  ident: 10.1016/j.jacl.2011.04.001_bib20
  article-title: Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia
  publication-title: Clin Cardiol
  doi: 10.1002/clc.4960240610
– volume: 81
  start-page: 582
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib27
  article-title: Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(97)00965-X
– volume: 7
  start-page: 419
  year: 2003
  ident: 10.1016/j.jacl.2011.04.001_bib65
  article-title: Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis
  publication-title: Ther Apher Dial
  doi: 10.1046/j.1526-0968.2003.00078.x
– volume: 8
  start-page: 383
  year: 2004
  ident: 10.1016/j.jacl.2011.04.001_bib66
  article-title: Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echocardiography after single LDL apheresis
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1526-0968.2004.00172.x
– volume: 9
  start-page: 142
  year: 2005
  ident: 10.1016/j.jacl.2011.04.001_bib68
  article-title: Is lipoprotein(a)-apheresis useful?
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1774-9987.2005.00236.x
– volume: 15
  start-page: 1233
  year: 2007
  ident: 10.1016/j.jacl.2011.04.001_bib80
  article-title: Current status of cardiovascular gene therapy
  publication-title: Molec Ther
  doi: 10.1038/sj.mt.6300175
– volume: 11
  start-page: 470
  year: 2009
  ident: 10.1016/j.jacl.2011.04.001_bib84
  article-title: Nutritional supplements and serum lipids: does anything work?
  publication-title: Curr Atheroscler Rep
  doi: 10.1007/s11883-009-0070-2
– start-page: 2863
  year: 2001
  ident: 10.1016/j.jacl.2011.04.001_bib3
  article-title: Familial hypercholesterolemia
– volume: 69
  start-page: 30
  year: 1999
  ident: 10.1016/j.jacl.2011.04.001_bib15
  article-title: Cholesterol lowering effects of dietary fiber: a meta-analysis
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/69.1.30
– volume: 41
  start-page: 1669
  year: 2007
  ident: 10.1016/j.jacl.2011.04.001_bib79
  article-title: ISIS 301012 Gene Therapy for Hypercholesterolemia: Sense, Antisense, or Nonsense?
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1K065
– volume: 50
  start-page: 1725
  year: 2004
  ident: 10.1016/j.jacl.2011.04.001_bib4
  article-title: Lipid disorders and mutations in the Apo B gene
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2004.038026
– volume: 6
  start-page: 1023
  year: 2010
  ident: 10.1016/j.jacl.2011.04.001_bib38
  article-title: Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/VHRM.S13496
– volume: 43
  start-page: 264
  year: 2002
  ident: 10.1016/j.jacl.2011.04.001_bib13
  article-title: Efficacy of Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)30168-1
– volume: 38
  start-page: 2071
  year: 1997
  ident: 10.1016/j.jacl.2011.04.001_bib53
  article-title: Decreased production of low-density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)37137-6
– volume: 35
  start-page: 1946
  year: 1994
  ident: 10.1016/j.jacl.2011.04.001_bib54
  article-title: Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG CoA reductase inhibitor therapy
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)39941-7
– ident: 10.1016/j.jacl.2011.04.001_bib8
– volume: 84
  start-page: 23
  year: 2000
  ident: 10.1016/j.jacl.2011.04.001_bib12
  article-title: Management of hypercholesterolemia
  publication-title: Med Clin North Am
  doi: 10.1016/S0025-7125(05)70205-4
– volume: 161
  start-page: 145
  year: 2011
  ident: 10.1016/j.jacl.2011.04.001_bib18
  article-title: Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2010.09.023
– volume: 345
  start-page: 1583
  year: 2001
  ident: 10.1016/j.jacl.2011.04.001_bib29
  article-title: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa011090
– volume: 97
  start-page: 69C
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib31
  article-title: National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by muscle experts
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.12.013
– volume: 168
  start-page: 1
  year: 2003
  ident: 10.1016/j.jacl.2011.04.001_bib23
  article-title: A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(02)00330-1
– volume: 106
  start-page: 3143
  year: 2002
  ident: 10.1016/j.jacl.2011.04.001_bib2
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
– volume: 105
  start-page: 2469
  year: 2002
  ident: 10.1016/j.jacl.2011.04.001_bib35
  article-title: Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000018744.58460.62
– volume: 123
  start-page: 459
  year: 2011
  ident: 10.1016/j.jacl.2011.04.001_bib1
  article-title: Executive Summary: Heart Disease and Stroke Statistics 2011 Update: A Report from the American Heart Association. American Heart Association Heart Disease and Stroke Statistics Writing Group
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e31820c7a50
– volume: 72
  start-page: 858
  year: 1994
  ident: 10.1016/j.jacl.2011.04.001_bib57
  article-title: The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study
  publication-title: Clin Investig
  doi: 10.1007/BF00190741
– volume: 345
  start-page: 811
  year: 1995
  ident: 10.1016/j.jacl.2011.04.001_bib59
  article-title: Familial Hypercholesterolemia Regression Study: a randomised trial of low-density-lipoprotein apheresis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)92961-4
– volume: 8
  start-page: 282
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib51
  article-title: LDL-apheresis therapy
  publication-title: Curr Treat Options Cardiovasc Med
  doi: 10.1007/s11936-006-0049-z
– volume: 92
  start-page: 152
  year: 2003
  ident: 10.1016/j.jacl.2011.04.001_bib28
  article-title: Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR∗ Trial)
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(03)00530-7
– volume: 96
  start-page: 421
  year: 1999
  ident: 10.1016/j.jacl.2011.04.001_bib72
  article-title: Is normal pregnancy atherogenic?
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS19980326
– volume: 28
  start-page: 202
  year: 2010
  ident: 10.1016/j.jacl.2011.04.001_bib83
  article-title: Nutraceuticals and atherosclerosis: human trials
  publication-title: Cardiovasc Ther
  doi: 10.1111/j.1755-5922.2010.00189.x
– volume: 93
  start-page: 1826
  year: 1996
  ident: 10.1016/j.jacl.2011.04.001_bib60
  article-title: LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment of coronary atherosclerosis
  publication-title: Circulation
  doi: 10.1161/01.CIR.93.10.1826
– volume: 32
  start-page: 144
  year: 1991
  ident: 10.1016/j.jacl.2011.04.001_bib71
  article-title: Lipid profiles during and after normal pregnancy
  publication-title: Gynecol Obstet Invest
  doi: 10.1159/000293016
– volume: 32
  start-page: 615
  year: 2010
  ident: 10.1016/j.jacl.2011.04.001_bib41
  article-title: Trip Study Group. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind controlled trial
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2010.04.014
– volume: 106
  start-page: 1564
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib21
  article-title: Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins
  publication-title: J Am Diet Assoc
  doi: 10.1016/j.jada.2006.07.009
– volume: 82
  start-page: 1489
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib61
  article-title: Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(98)00692-4
– volume: 51
  start-page: 976
  year: 2002
  ident: 10.1016/j.jacl.2011.04.001_bib25
  article-title: Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia
  publication-title: Metabolism
  doi: 10.1053/meta.2002.34016
– volume: 21
  start-page: 481
  year: 2001
  ident: 10.1016/j.jacl.2011.04.001_bib82
  article-title: Evaluation of the antihyperlipidemic properties of dietary supplements
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.21.5.481.34499
– volume: 9
  start-page: I91
  issue: 1Supppl
  year: 1989
  ident: 10.1016/j.jacl.2011.04.001_bib19
  article-title: Dietary treatment of familial hypercholesterolemia
  publication-title: Arteriosclerosis
– volume: 82
  start-page: 82U
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib45
  article-title: Treatment of hyperlipidemia with combined niacin-statin regimens
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(98)00955-2
– volume: 93
  start-page: 4200
  year: 2008
  ident: 10.1016/j.jacl.2011.04.001_bib6
  article-title: Recognition and management of dyslipidemia in children and adolescents
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-1270
– volume: 337
  start-page: 509
  year: 2008
  ident: 10.1016/j.jacl.2011.04.001_bib9
  article-title: Familial hypercholesterolemia: summary of NICE guidance
  publication-title: BMJ
  doi: 10.1136/bmj.a1095
– volume: 19
  start-page: 11
  year: 2004
  ident: 10.1016/j.jacl.2011.04.001_bib64
  article-title: Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia
  publication-title: J Clin Apher
  doi: 10.1002/jca.20000
– volume: 81
  start-page: 407
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib55
  article-title: Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(97)00947-8
– volume: 97
  start-page: 376
  year: 2006
  ident: 10.1016/j.jacl.2011.04.001_bib22
  article-title: Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.08.056
– volume: 95
  start-page: 1
  year: 1992
  ident: 10.1016/j.jacl.2011.04.001_bib56
  article-title: Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators
  publication-title: Atherosclerosis
  doi: 10.1016/0021-9150(92)90170-L
– volume: 139
  start-page: 271
  year: 2009
  ident: 10.1016/j.jacl.2011.04.001_bib16
  article-title: Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake
  publication-title: J Nutr
  doi: 10.3945/jn.108.095125
– volume: 5
  start-page: 507
  year: 2009
  ident: 10.1016/j.jacl.2011.04.001_bib47
  article-title: Myopathy with statin-fibrate combination therapy: clinical considerations
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2009.151
– volume: 11
  start-page: 2
  year: 2007
  ident: 10.1016/j.jacl.2011.04.001_bib67
  article-title: Apheresis in coronary heart disease with elevated Lp(a): a review of Lp(a) as a risk factor and its management
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1744-9987.2007.00449.x
– volume: 87
  start-page: 476
  year: 2001
  ident: 10.1016/j.jacl.2011.04.001_bib46
  article-title: Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(00)01410-7
– volume: 4
  start-page: 350
  year: 2010
  ident: 10.1016/j.jacl.2011.04.001_bib81
  article-title: NLA Symposium on Familial Hypercholesterolemia. Novel therapies and new targets of treatment familial hypercholesterolemia
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2010.08.015
– volume: 22
  start-page: 43
  year: 2011
  ident: 10.1016/j.jacl.2011.04.001_bib14
  article-title: Lowering LDL cholesterol through diet: potential role in the statin era
  publication-title: Curr Opin Lipidol
  doi: 10.1097/MOL.0b013e328340b8e7
– volume: 82
  start-page: 35U
  year: 1998
  ident: 10.1016/j.jacl.2011.04.001_bib43
  article-title: Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(98)00952-7
SSID ssj0055705
Score 2.2702124
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage S38
SubjectTerms Adult
Blood Component Removal - methods
Contraindications
Coronary Disease - etiology
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hyperlipoproteinemia Type II - complications
Hyperlipoproteinemia Type II - drug therapy
Life Style
Lipoproteins, LDL - isolation & purification
Pregnancy
Pregnancy Complications - therapy
Title Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1933287411005368
https://dx.doi.org/10.1016/j.jacl.2011.04.001
https://www.ncbi.nlm.nih.gov/pubmed/21600528
https://www.proquest.com/docview/868995587
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUhveQSWto0m7ZhDr0Fd23r072F0LBtSSi0gdyEJEuwYeMN2c21_6X_tDO2vG0P2UAvNjYaZDSj0ZM884ax9y4aIUqeCl_hRSBiLXwyZaGb1kkVWxVLyne-uFSzK_HlWl7vsLMxF4bCKrPvH3x6763zm2kezendfD79jtCDE1s7kZ5JrijhVwhNtv7h5ybMgxim5PBnmRfUOifODDFeNy4sMo0nkWhXjy1Oj4HPfhE6f872M3qE0-EDX7Cd2L1kv_6EsMAyQV_KAq0KZrjFvCfv1pMh4O127lYw76Dn3IDMqLr6CLQFvUXxobzSCijlBBAYQibNXgBVuG7hL1VCT5G8hm-uiwvA5629vmJX559-nM2KXHmhCELX60Kn2DbGx9a42sTEgwtt6XnyQSre6jI0yQsCS97JJtW1U5WXXAftlA41IsgDttstu3jIICRVN0Y3LqBIUK2LUkdXoiVQkXstJqwah9yGTEtO1TEWdow_u7GkJktqsqWgILwJO9nI3A2kHFtb81GTdkw3RQdpcc3YKiU3Uv8Y5JNyMBqLxZlKv19QE8uHlTUK97ZSGj1hrwcj2nx8XSk6nzdH_9npG7Y3nHXT6dBbtru-f4jvECyt_XE_G47Zs9PPX2eXvwGhPheu
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcAFgXhty2MO3FDYJH6GG6qoFmgrJFqpN8t2bGmrbbbqbq_8l_5TZhJngUMXiUuiRB7F8kzGn-2Zbxh756IRouSp8BVeBCLWwidTFrppnVSxVbGkfOfjEzU7E1_P5fkOOxhzYSisMvv-waf33jq_mebRnF7N59MfCD04sbUT6Znkytxj94Xkmgj0P_zcxHkQxZQcjpZ5Qc1z5swQ5HXhwiLzeBKLdnXX7HQX-uxnocPH7FGGj_Bp6OETthO7p-z2dwwLLBP0tSzQrGCGa8xrcm89GwLeLuduBfMOetINyJSqq49Aa9BLFB_qK62Ack4AkSFk1uwFUInrFv7QJfQcyWv47rq4AHze-tVn7Ozw8-nBrMilF4ogdL0udIptY3xsjatNTDy40JaeJx-k4q0uQ5O8ILTknWxSXTtVeRz7oJ3SoUYI-ZztdssuvmQQkqoboxsXUCSo1kWpoyvRFKjKvRYTVo1DbkPmJafyGAs7BqBdWFKTJTXZUlAU3oS938hcDawcW1vzUZN2zDdFD2lx0tgqJTdSf1nkP-VgNBaLvyqdv6AmljcraxQubqU0esJeDEa06XxdKdqgN3v_-dG37MHs9PjIHn05-bbPHg4b37RV9Irtrq9v4mtETmv_pv8zfgHizRlA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Management+of+familial+hypercholesterolemias+in+adult+patients%3A+recommendations+from+the+National+Lipid+Association+Expert+Panel+on+Familial+Hypercholesterolemia&rft.jtitle=Journal+of+clinical+lipidology&rft.au=Ito%2C+Matthew+K&rft.au=McGowan%2C+Mary+P&rft.au=Moriarty%2C+Patrick+M&rft.date=2011-06-01&rft.issn=1933-2874&rft.volume=5&rft.issue=3+Suppl&rft.spage=S38&rft_id=info:doi/10.1016%2Fj.jacl.2011.04.001&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-2874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-2874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-2874&client=summon